Immunotherapy of Peritoneal Carcinomatosis with Catumaxomab

Publisher： Karger

E-ISSN： 2296-5262|34|3|86-87

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.3, 2011-02, pp. : 86-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial

By  

Oncology Research and Treatment, Vol. 34, Iss. 3, 2011-02 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

An Unusual Case of Peritoneal Carcinomatosis

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-09 ,pp. : 315-325

Karger

Access to resources Recommend Favorite

Role of CRS plus HIPEC in gastric cancer peritoneal carcinomatosis

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 248-248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Looking up: Recent advances in understanding and treating peritoneal carcinomatosis

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 4, 2015-07 ,pp. : 283-298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peritoneal carcinomatosis after risk‐reducing surgery in BRCA1/2 mutation carriers

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 952-959

John Wiley & Sons Inc

Access to resources Recommend Favorite